In the last decade, the discovery of potent and selective BChE inhibitors has inspired many efforts, and many molecules have been identified as excellent BChE inhibitors with good activity toward AD treatment in animal models [8,9,10]. The gene discussed is BCHE; the disease is Alzheimer disease.